A detailed history of Private Advisor Group, LLC transactions in Cor Medix Inc. stock. As of the latest transaction made, Private Advisor Group, LLC holds 31,460 shares of CRMD stock, worth $218,647. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,460
Previous 31,460 -0.0%
Holding current value
$218,647
Previous $133,000 2.26%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024

SELL
$3.0 - $4.01 $1,020 - $1,363
-340 Reduced 1.07%
31,460 $118,000
Q3 2023

Nov 02, 2023

SELL
$3.6 - $4.46 $21,996 - $27,250
-6,110 Reduced 16.12%
31,800 $117,000
Q4 2022

Jan 18, 2023

BUY
$2.81 - $4.45 $562 - $890
200 Added 0.53%
37,910 $0
Q3 2022

Oct 14, 2022

BUY
$2.82 - $7.52 $47,940 - $127,840
17,000 Added 82.09%
37,710 $107,000
Q2 2022

Jul 13, 2022

SELL
$2.73 - $5.61 $3,464 - $7,119
-1,269 Reduced 5.77%
20,710 $83,000
Q1 2022

May 12, 2022

BUY
$3.83 - $6.24 $7,277 - $11,856
1,900 Added 9.46%
21,979 $120,000
Q4 2021

Feb 10, 2022

BUY
$4.47 - $5.56 $7,599 - $9,452
1,700 Added 9.25%
20,079 $91,000
Q3 2021

Oct 14, 2021

SELL
$4.46 - $7.11 $11,150 - $17,775
-2,500 Reduced 11.97%
18,379 $85,000
Q1 2021

Apr 22, 2021

SELL
$6.84 - $17.58 $7,592 - $19,513
-1,110 Reduced 5.05%
20,879 $209,000
Q4 2020

Apr 01, 2021

SELL
$5.0 - $9.15 $1,000 - $1,830
-200 Reduced 0.9%
21,989 $163,000
Q3 2020

Nov 02, 2020

SELL
$3.96 - $6.15 $15,840 - $24,600
-4,000 Reduced 15.27%
22,189 $134,000
Q2 2020

Aug 17, 2020

BUY
$3.08 - $6.56 $7,761 - $16,531
2,520 Added 10.65%
26,189 $165,000
Q4 2019

Feb 10, 2020

BUY
$4.96 - $7.75 $13,104 - $20,475
2,642 Added 12.56%
23,669 $172,000
Q3 2019

Nov 13, 2019

SELL
$6.38 - $9.69 $16,588 - $25,194
-2,600 Reduced 11.0%
21,027 $134,000
Q2 2019

Aug 14, 2019

BUY
$5.93 - $10.57 $40,324 - $71,876
6,800 Added 40.41%
23,627 $212,000
Q1 2019

May 13, 2019

BUY
$6.95 - $13.25 $116,947 - $222,957
16,827 New
16,827 $159,000

Others Institutions Holding CRMD

About CorMedix Inc.


  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $286M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.